List of works - Wei Zhao

A Population and Developmental Pharmacokinetic Analysis To Evaluate and Optimize Cefotaxime Dosing Regimen in Neonates and Young Infants

scientific article published on 29 August 2016

A microscale HPLC-UV method for the determination of latamoxef in plasma: An adapted method for therapeutic drug monitoring in neonates

scientific article published on 17 April 2018

A model-based approach for the evaluation of once daily dosing of lamivudine in HIV-infected children

scientific article published on May 2014

Aciclovir CSF concentration in children with viral encephalitis: is it adequate?

scientific article published on 01 September 2018

Amikacin Maturation Model as a Marker of Renal Maturation to Predict Glomerular Filtration Rate and Vancomycin Clearance in Neonates

scientific article published on 01 December 2013

An adapted LC-MS/MS method for the determination of free plasma concentration of cefoperazone in children: Age-dependent protein binding

scientific article published on 29 March 2020

Author’s Reply to Standing et al. Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design

scientific article published on 01 December 2015

Body Surface Area-Based Dosing Regimen of Caspofungin in Children: a Population Pharmacokinetics Confirmatory Study

scientific article published on 24 June 2019

Cefotiam Treatment in Children: Evidence of Subtherapeutic Levels

scientific article published on 02 April 2020

Clinical Utility and Safety of a Model-Based Patient-Tailored Dose of Vancomycin in Neonates

scientific article published on 19 January 2016

Commentary on the MID3 Good Practices Paper

scientific article

Covariate effects and population pharmacokinetics of lamivudine in HIV-infected children

scientific article published on May 2014

Cystatin C as a potential biomarker for dosing of renally excreted drugs

scientific article published on 28 May 2015

Determination of cefoperazone and sulbactam in serum by HPLC-MS/MS: An adapted method for therapeutic drug monitoring in children

scientific article published on 17 November 2017

Determination of ciprofloxacin in plasma by micro-liquid chromatography-mass spectrometry: an adapted method for neonates.

scientific article

Developmental Pharmacogenetics of SLCO2B1 on Montelukast Pharmacokinetics in Chinese Children

scientific article published on 27 December 2019

Developmental pharmacogenetics of CYP2C19 in neonates and young infants: omeprazole as a probe drug

scientific article

Developmental pharmacogenetics of immunosuppressants in pediatric organ transplantation.

scientific article published on December 2010

Developmental population pharmacokinetics of caffeine in Chinese premature infants with apnea of prematurity: a post-marketing study to support pediatric labeling in China

scientific article published on 20 July 2020

Developmental population pharmacokinetics-pharmacodynamics and dosing optimization of cefoperazone in children

scientific article published on 04 March 2020

Dosing regimens of antibiotics in neonates: Variations in clinical practice and what should be done?

scientific article published on 19 July 2016

Drug Elimination Alteration in Acute Lymphoblastic Leukemia Mediated by Renal Transporters and Glomerular Filtration

scientific article published on 02 August 2020

Early target attainment of azithromycin therapy in children with lower respiratory tract infections

scientific article published on 01 October 2018

External Evaluation of Population Pharmacokinetic Models of Vancomycin in Neonates: The transferability of published models to different clinical settings.

scientific article published on April 2013

Extremely low dose of 6-mercaptopurine in a Chinese child with acute lymphoblastic leukaemia and multiple pharmacogenetic mutations

scientific article published on 07 September 2020

First dose in neonates: Pharmacokinetic Bridging study from Juvenile Mice to Neonates for Drugs Metabolized by CYP3A

scientific article published on 13 May 2020

First dose in neonates: are juvenile mice, adults and in vitro-in silico data predictive of neonatal pharmacokinetics of fluconazole

scientific article

How to use vancomycin optimally in neonates: remaining questions

scientific article published on 04 August 2015

Impact of glutathione S-transferase M1 and T1 on anti-tuberculosis drug-induced hepatotoxicity in Chinese pediatric patients

scientific article

Individualization of valganciclovir prophylaxis for cytomegalovirus infection in pediatric kidney transplant patients.

scientific article published in June 2012

Limited sampling strategy for estimating individual exposure of tacrolimus in pediatric kidney transplant patients.

scientific article published in December 2011

Limited sampling strategy using Bayesian estimation for estimating individual exposure of the once-daily prolonged-release formulation of tacrolimus in kidney transplant children.

scientific article published on 4 December 2012

Off-label use of medicines in neonates, infants, children, and adolescents: a joint policy statement by the European Academy of Paediatrics and the European society for Developmental Perinatal and Pediatric Pharmacology

scientific article published on 03 January 2020

Off-label use of tacrolimus in children with Henoch-Schönlein purpura nephritis: a pilot study

scientific article published on 13 March 2018

Off-label use of tacrolimus in children with glomerular disease: Effectiveness, safety and pharmacokinetics

scientific article published on 14 January 2020

Optimisation of vancomycin exposure in neonates based on the best level of evidence

scientific article published on 18 May 2019

Optimizing micafungin dosing in children

scientific article published in November 2012

Oral drugs used to treat persistent pulmonary hypertension of the newborn

scientific article published on 12 November 2020

PK/PD modeling of 5-hydroxytryptophan (5-HTP) challenge test with cortisol measurement in serum and saliva

scientific article published on 01 April 2020

Paediatric drug development: are population models predictive of pharmacokinetics across paediatric populations?

scientific article

Paediatric drugs trials in China

scientific article published on 31 March 2020

Penetration of cefotaxime into cerebrospinal fluid in neonates and young infants

scientific article published on 5 February 2018

Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates

scientific article published on 10 January 2016

Pharmacogenetic Determinant of the Drug Interaction Between Tacrolimus and Omeprazole

scientific article published on 01 December 2012

Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimus.

scientific article published on 4 February 2018

Pharmacokinetic Interaction Between Tacrolimus and Amlodipine in a Renal Transplant Child

scientific article published on 01 April 2012

Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design.

scientific article

Pharmacokinetics and dosage individualization of ganciclovir and valganciclovir in an infant with nephrotic syndrome associated with cytomegalovirus infection.

scientific article published on 19 November 2013

Pharmacokinetics and safety of fluconazole and micafungin in neonates with systemic candidiasis: a randomized open-label clinical trial.

scientific article

Pilot Phase II study of mazindol in children with attention deficit/hyperactivity disorder.

scientific article

Pilot Study of Model-Based Dosage Individualization of Ganciclovir in Neonates and Young Infants with Congenital Cytomegalovirus Infection.

scientific article

Population Pharmacokinetic Analysis of Isoniazid among Pulmonary Tuberculosis Patients from China

scientific article published on 21 February 2020

Population Pharmacokinetic Study of Cefathiamidine in Infants With Augmented Renal Clearance

publication published on 15 March 2021

Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Chinese Infants

scientific article published on 29 September 2020

Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Neonates and Young Infants

scientific article published on 29 January 2019

Population Pharmacokinetics and Dosing Optimization of Azithromycin in Children with Community-Acquired Pneumonia.

scientific article published on 27 August 2018

Population Pharmacokinetics and Dosing Optimization of Imipenem in Children with Hematological Malignancies

scientific article published on 24 May 2019

Population Pharmacokinetics of Tacrolimus in Children with Nephrotic Syndrome

scientific article published on 10 April 2018

Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants

scientific article published on 01 August 2019

Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome.

scientific article

Population pharmacokinetics and dose optimization of ceftriaxone for children with community-acquired pneumonia

scientific article published on 25 June 2020

Population pharmacokinetics and dosing optimisation of ceftazidime in infants.

scientific article published on 29 January 2018

Population pharmacokinetics and dosing optimization of azlocillin in neonates with early-onset sepsis: a real-world study

scientific article published on 14 November 2020

Population pharmacokinetics and dosing optimization of cefathiamidine in children with hematologic infection.

scientific article

Population pharmacokinetics and dosing optimization of latamoxef in neonates and young infants

scientific article published on 22 November 2018

Population pharmacokinetics and dosing optimization of metformin in Chinese patients with type 2 diabetes mellitus

scientific article published on 01 November 2020

Population pharmacokinetics and dosing optimization of teicoplanin in children with malignant haematological disease.

scientific article

Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease

scientific article

Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV-infected infants and toddlers

scientific article

Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patients

scientific article

Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients.

scientific article published on 28 October 2009

Population pharmacokinetics of abacavir in infants, toddlers and children ⬇️

scientific article published on June 1, 2013

Population pharmacokinetics of cefotaxime and dosage recommendations in children with sickle cell disease

scientific article published on 29 January 2018

Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age.

scientific article

Population pharmacokinetics of ganciclovir after valganciclovir in renal transplant children

scientific article published on 16 September 2019

Population pharmacokinetics of ganciclovir following administration of valganciclovir in paediatric renal transplant patients.

scientific article published in January 2009

Precision therapy of 6-mercaptopurine in Chinese children with acute lymphoblastic leukaemia

scientific article published on 19 February 2020

Prediction of unbound ceftriaxone concentration in children: Simple bioanalysis method and basic mathematic equation

scientific article published on 05 October 2020

Principles and applications of pharmacometrics in drug evaluation in children

scientific article published on 16 February 2018

Principles of Therapeutic Drug Monitoring ⬇️

scientific article published on January 1, 2011

Safety study of Ciprofloxacin in newborn mice

scientific article

The importance of knowing how vancomycin is measured when interpreting its pharmacokinetic results

scientific article published in June 2013

Therapeutic guidelines for prescribing antibiotics in neonates should be evidence-based: a French national survey

scientific article published on 27 January 2015

Use of antibacterial agents in the neonate: 50 years of experience with vancomycin administration.

scientific article

Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring

scientific article published on 19 December 2012

List of works by Wei Zhao

A Population and Developmental Pharmacokinetic Analysis To Evaluate and Optimize Cefotaxime Dosing Regimen in Neonates and Young Infants

A microscale HPLC-UV method for the determination of latamoxef in plasma: An adapted method for therapeutic drug monitoring in neonates

A model-based approach for the evaluation of once daily dosing of lamivudine in HIV-infected children

Aciclovir CSF concentration in children with viral encephalitis: is it adequate?

Amikacin Maturation Model as a Marker of Renal Maturation to Predict Glomerular Filtration Rate and Vancomycin Clearance in Neonates

An adapted LC-MS/MS method for the determination of free plasma concentration of cefoperazone in children: Age-dependent protein binding

Author’s Reply to Standing et al. Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design

Body Surface Area-Based Dosing Regimen of Caspofungin in Children: a Population Pharmacokinetics Confirmatory Study

Cefotiam Treatment in Children: Evidence of Subtherapeutic Levels

Clinical Utility and Safety of a Model-Based Patient-Tailored Dose of Vancomycin in Neonates

Commentary on the MID3 Good Practices Paper

Covariate effects and population pharmacokinetics of lamivudine in HIV-infected children

Cystatin C as a potential biomarker for dosing of renally excreted drugs

Determination of cefoperazone and sulbactam in serum by HPLC-MS/MS: An adapted method for therapeutic drug monitoring in children

Determination of ciprofloxacin in plasma by micro-liquid chromatography-mass spectrometry: an adapted method for neonates.

Developmental Pharmacogenetics of SLCO2B1 on Montelukast Pharmacokinetics in Chinese Children

Developmental pharmacogenetics of CYP2C19 in neonates and young infants: omeprazole as a probe drug

Developmental pharmacogenetics of immunosuppressants in pediatric organ transplantation.

Developmental population pharmacokinetics of caffeine in Chinese premature infants with apnea of prematurity: a post-marketing study to support pediatric labeling in China

Developmental population pharmacokinetics-pharmacodynamics and dosing optimization of cefoperazone in children

Dosing regimens of antibiotics in neonates: Variations in clinical practice and what should be done?

Drug Elimination Alteration in Acute Lymphoblastic Leukemia Mediated by Renal Transporters and Glomerular Filtration

Early target attainment of azithromycin therapy in children with lower respiratory tract infections

External Evaluation of Population Pharmacokinetic Models of Vancomycin in Neonates: The transferability of published models to different clinical settings.

Extremely low dose of 6-mercaptopurine in a Chinese child with acute lymphoblastic leukaemia and multiple pharmacogenetic mutations

First dose in neonates: Pharmacokinetic Bridging study from Juvenile Mice to Neonates for Drugs Metabolized by CYP3A

First dose in neonates: are juvenile mice, adults and in vitro-in silico data predictive of neonatal pharmacokinetics of fluconazole

How to use vancomycin optimally in neonates: remaining questions

Impact of glutathione S-transferase M1 and T1 on anti-tuberculosis drug-induced hepatotoxicity in Chinese pediatric patients

Individualization of valganciclovir prophylaxis for cytomegalovirus infection in pediatric kidney transplant patients.

Limited sampling strategy for estimating individual exposure of tacrolimus in pediatric kidney transplant patients.

Limited sampling strategy using Bayesian estimation for estimating individual exposure of the once-daily prolonged-release formulation of tacrolimus in kidney transplant children.

Off-label use of medicines in neonates, infants, children, and adolescents: a joint policy statement by the European Academy of Paediatrics and the European society for Developmental Perinatal and Pediatric Pharmacology

Off-label use of tacrolimus in children with Henoch-Schönlein purpura nephritis: a pilot study

Off-label use of tacrolimus in children with glomerular disease: Effectiveness, safety and pharmacokinetics

Optimisation of vancomycin exposure in neonates based on the best level of evidence

Optimizing micafungin dosing in children

Oral drugs used to treat persistent pulmonary hypertension of the newborn

PK/PD modeling of 5-hydroxytryptophan (5-HTP) challenge test with cortisol measurement in serum and saliva

Paediatric drug development: are population models predictive of pharmacokinetics across paediatric populations?

Paediatric drugs trials in China

Penetration of cefotaxime into cerebrospinal fluid in neonates and young infants

Pharmacodynamics of vancomycin for CoNS infection: experimental basis for optimal use of vancomycin in neonates

Pharmacogenetic Determinant of the Drug Interaction Between Tacrolimus and Omeprazole

Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimus.

Pharmacokinetic Interaction Between Tacrolimus and Amlodipine in a Renal Transplant Child

Pharmacokinetic Studies in Neonates: The Utility of an Opportunistic Sampling Design.

Pharmacokinetics and dosage individualization of ganciclovir and valganciclovir in an infant with nephrotic syndrome associated with cytomegalovirus infection.

Pharmacokinetics and safety of fluconazole and micafungin in neonates with systemic candidiasis: a randomized open-label clinical trial.

Pilot Phase II study of mazindol in children with attention deficit/hyperactivity disorder.

Pilot Study of Model-Based Dosage Individualization of Ganciclovir in Neonates and Young Infants with Congenital Cytomegalovirus Infection.

Population Pharmacokinetic Analysis of Isoniazid among Pulmonary Tuberculosis Patients from China

Population Pharmacokinetic Study of Cefathiamidine in Infants With Augmented Renal Clearance

Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Chinese Infants

Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Neonates and Young Infants

Population Pharmacokinetics and Dosing Optimization of Azithromycin in Children with Community-Acquired Pneumonia.

Population Pharmacokinetics and Dosing Optimization of Imipenem in Children with Hematological Malignancies

Population Pharmacokinetics of Tacrolimus in Children with Nephrotic Syndrome

Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants

Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome.

Population pharmacokinetics and dose optimization of ceftriaxone for children with community-acquired pneumonia

Population pharmacokinetics and dosing optimisation of ceftazidime in infants.

Population pharmacokinetics and dosing optimization of azlocillin in neonates with early-onset sepsis: a real-world study

Population pharmacokinetics and dosing optimization of cefathiamidine in children with hematologic infection.

Population pharmacokinetics and dosing optimization of latamoxef in neonates and young infants

Population pharmacokinetics and dosing optimization of metformin in Chinese patients with type 2 diabetes mellitus

Population pharmacokinetics and dosing optimization of teicoplanin in children with malignant haematological disease.

Population pharmacokinetics and dosing optimization of vancomycin in children with malignant hematological disease

Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV-infected infants and toddlers

Population pharmacokinetics and pharmacogenetics of mycophenolic acid following administration of mycophenolate mofetil in de novo pediatric renal-transplant patients

Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients.

Population pharmacokinetics of abacavir in infants, toddlers and children ⬇️

Population pharmacokinetics of cefotaxime and dosage recommendations in children with sickle cell disease

Population pharmacokinetics of ciprofloxacin in neonates and young infants less than three months of age.

Population pharmacokinetics of ganciclovir after valganciclovir in renal transplant children

Population pharmacokinetics of ganciclovir following administration of valganciclovir in paediatric renal transplant patients.

Precision therapy of 6-mercaptopurine in Chinese children with acute lymphoblastic leukaemia

Prediction of unbound ceftriaxone concentration in children: Simple bioanalysis method and basic mathematic equation

Principles and applications of pharmacometrics in drug evaluation in children